Author:
Falkenhorst Johanna,Hamacher Rainer,Bauer Sebastian
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference52 articles.
1. Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era: a population-based study in western Sweden;Nilsson;Cancer,2005
2. Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor;Heinrich;J Clin Oncol,2003
3. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors;Hirota;Science,1998
4. Ten-year progression-free and overall survival in patients with unresectable or metastatic GI stromal tumors: long-term analysis of the European Organisation for Research and Treatment of Cancer, Italian Sarcoma Group, and Australasian Gastrointestinal Trials Group intergroup phase III randomized trial on imatinib at two dose levels;Casali;J Clin Oncol,2017
5. Gastrointestinal stromal tumours: origin and molecular oncology;Corless;Nat Rev Cancer,2011
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献